title: Postmarketing modifications in the safety labeling of the new antiepileptics.
authors.affiliation: Department of Pharmacy, University of Virginia Health Systems, Charlottesville, VA 22908, USA.
authors.forename: Marcia L
authors.initials: ML
authors.lastname: Buck
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Gurka
authors.forename: Howard P
authors.initials: HP
authors.lastname: Goodkin
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards / Q000706:statistics & numerical data / Q000639:trends*; D000927:Anticonvulsants / Q000009:adverse effects* / Q000191:economics; D017277:Drug Approval / Q000706:statistics & numerical data; D004348:Drug Labeling / Q000592:standards*; D004335:Drug and Narcotic Control / Q000706:statistics & numerical data / Q000639:trends*; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000592:standards / Q000706:statistics & numerical data / Q000639:trends*; D014481:United States
chemical_list: D000927:Anticonvulsants